Health
Bahrain Approves China’s Sinopharm Covid-19 Vaccine – BloombergQuint
Bahrain Approves China’s Sinopharm Covid-19 Vaccine
(Bloomberg) — Bahrain approved the registration of the Sinopharm Group Co Ltd. vaccine against the coronavirus, about a week after the United Arab Emirates registered the Chinese-made vaccine.
Results from Phase III clinical trials showed an 86% efficacy rate, a 99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of Covid-19, the National Health Regulatory Authority said in a statement Sunday. Bahrains findings are based on data from more…
-
General7 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General23 hours agoFederal government funding extends cohealth GP services until July 2026
-
General10 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique
-
Noosa News22 hours agoFree flow of information vital to WHS – Proctor
